Leva Capital

FluidAI is a medical technology company focused on post-operative care, combining artificial intelligence with in-body data to improve patient monitoring. The company develops a smart catheter system that enables proactive post-operative care by detecting complications at onset and delivering critical health data to healthcare providers ahead of time.

Eli is a company focused on empowering women to manage their health by providing insights into their hormone profiles. It has developed an at-home device that monitors hormones using saliva samples, allowing for daily tracking of hormonal changes. Alongside the device, Eli offers an app that delivers personalized insights based on the collected data. The primary aim of Eli is to offer women a reliable and effective means to take charge of their fertility and contraception choices, thereby enhancing their overall health and well-being.

LUCID curates and creates personalized therapeutic music using biometrics, psychometrics, and AI to improve mental health and wellness. The company is creating experiences to assist consumers and employers all over the world in better managing anxiety and stress. They have created wellness-focused experiences that deliver benefits in as little as 5 minutes using innovative human-centered design at the intersection of art, science, and technology.

FluidAI is a medical technology company focused on post-operative care, combining artificial intelligence with in-body data to improve patient monitoring. The company develops a smart catheter system that enables proactive post-operative care by detecting complications at onset and delivering critical health data to healthcare providers ahead of time.

iApotheca specializes in pharmacy software development. Its core product is a prescription delivery management system designed to enhance pharmacy revenue and operational efficiency by streamlining delivery services.

Qualisure Diagnostics is a biotechnology company focused on making precision oncology the standard of care through the development of innovative diagnostic tools. The company harnesses big data and machine learning, utilizing proprietary algorithms to analyze extensive genomic databases and identify key biomarkers linked to patient survival outcomes. This capability allows for the creation of diagnostic tests that provide oncologists with vital biological information to tailor cancer treatment plans effectively. By minimizing unnecessary surgeries and treatments, Qualisure Diagnostics aims to enhance patient outcomes while also reducing healthcare costs. Their cloud-based platform enables global deployment of these diagnostic tests, supported by a central marketplace that simplifies test selection, ordering, and data exchange among healthcare stakeholders. Ultimately, Qualisure Diagnostics empowers physicians, patients, and other test developers with actionable insights, contributing to a more effective and efficient cancer care approach.

ManagingLife provides a digital pain management platform centered on the Manage My Pain solution. The company leverages a proprietary data asset to support a data-driven approach that helps patients and clinicians track and analyze chronic pain, communicate with healthcare providers, and share information with insurers. Delivered as a SaaS offering, the platform aims to lower costs for insurers and health systems by improving patient outcomes, reducing medical spending, and shortening disability claims. The solution has been widely adopted, including by hospitals, health systems, and insurers across North America, and is described as one of the most downloaded pain apps, with over 80,000 users worldwide. By enabling understanding of chronic conditions and remote measurement of progress, the platform supports better care management and decision-making.